Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes.

[1]  L. Fauchier,et al.  Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. , 1997, Journal of the American College of Cardiology.

[2]  P. Ponikowski,et al.  Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[3]  D J van Veldhuisen,et al.  Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[4]  M. Elam,et al.  Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. , 1997, Circulation.

[5]  W. Abraham,et al.  Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. , 1996, Circulation.

[6]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[7]  J. Port,et al.  Cardiac adrenergic receptor effects of carvedilol. , 1996, European heart journal.

[8]  J. Le Heuzey,et al.  Effects of bisoprolol on heart rate variability in heart failure. , 1996, The American journal of cardiology.

[9]  G. Jennings,et al.  Adverse consequences of high sympathetic nervous activity in the failing human heart. , 1995, Journal of the American College of Cardiology.

[10]  M. Turiel,et al.  Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. , 1995, European heart journal.

[11]  L. Wilkins.  A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.

[12]  S. Cerutti,et al.  Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. , 1994, British heart journal.

[13]  K. Swedberg,et al.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.

[14]  I. Meredith,et al.  Cardiac Sympathetic Nervous Activit in Congestive Heart Failure Evidence for Increased Neuronal Norepinephrine Release and Preserved Neuronal Uptake , 1993, Circulation.

[15]  P. Bjerregaard,et al.  Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. , 1993, The American journal of cardiology.

[16]  D. Renlund,et al.  beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[17]  P. Binkley,et al.  Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. , 1993, Journal of the American College of Cardiology.

[18]  G. PORENTA,et al.  Prognostic Value of Heart Rate Variability in Patients Awaiting Cardiac Transplantation , 1992, Pacing and clinical electrophysiology : PACE.

[19]  D. Ewing,et al.  Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease. , 1992, The American journal of cardiology.

[20]  P. Binkley,et al.  Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. , 1991, Journal of the American College of Cardiology.

[21]  D. Ferguson,et al.  Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: Evidence from direct micronenrographic recordings , 1990 .

[22]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[23]  R. Carney,et al.  Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. , 1988, The American journal of cardiology.

[24]  K. Egstrup.  Transient myocardial ischemia after abrupt withdrawal of antianginal therapy in chronic stable angina. , 1988, The American journal of cardiology.

[25]  R J Cohen,et al.  Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. , 1988, The American journal of cardiology.

[26]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[27]  A. Mark,et al.  Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. , 1986, Circulation.

[28]  A. Marshall,et al.  Abrupt withdrawal of atenolol in patients with severe angina: comparison with the effects of treatment. , 1986, British heart journal.

[29]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[30]  L. Rydén,et al.  A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. , 1983, The New England journal of medicine.

[31]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[32]  S. Langlois,et al.  Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol. , 1982, American heart journal.

[33]  S. Langlois,et al.  Metoprolol withdrawal phenomena: Mechanism and prevention , 1982, Clinical pharmacology and therapeutics.

[34]  K. Swedberg,et al.  PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.

[35]  E. Varnauskas,et al.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.

[36]  R. Verrier,et al.  The Effect of Vagus Nerve Stimulation upon Vulnerability of the Canine Ventricle: Role of Sympathetic‐Parasympathetic Interactions , 1975, Circulation.